Ampio Pharmaceuticals, Inc. Contracts & Agreements

Amendment No. 2 to Employment Agreement dated October 1, 2023 by and between Ampio Pharmaceuticals, Inc. and Michael A. Martino (Filed With SEC on October 4, 2023)

Ampio Pharmaceuticals, Inc. 2023 Stock and Incentive Plan (Filed With SEC on August 1, 2023)

Sublease Agreement entered into February 16, 2023 but effective March 1, 2023 by and between Ampio Pharmaceuticals, Inc. and Utility Global, Inc (Filed With SEC on May 8, 2023)

Amendment No. 1 to Employment Agreement dated August 30, 2022 by and between Ampio Pharmaceuticals, Inc. and Michael A. Martino (Filed With SEC on September 1, 2022)

Research Services Agreement between the Registrant and Trauma Research LLC, dated February 4, 2022 (Filed With SEC on May 16, 2022)

Personal Services Agreement between the Registrant and Dr. Bar-Or, dated February 4, 2022 (Filed With SEC on May 16, 2022)

Specimen Common Stock Certificate of the Registrant (Filed With SEC on March 29, 2022)

2019 Stock Incentive Plan and forms of option agreements (Filed With SEC on March 29, 2022)

Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Michael Macaluso, dated October 11, 2021 (Filed With SEC on March 29, 2022)

Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Holli Cherevka, dated October 11, 2021 (Filed With SEC on March 29, 2022)

Employment Agreement between Ampio Pharmaceuticals, Inc. and Daniel Stokely, dated October 11, 2021 (Filed With SEC on March 29, 2022)

Form of Indemnification Agreement between Ampio Pharmaceuticals, Inc. and certain directors, executive officers and key employees (Filed With SEC on March 29, 2022)

Form of Warrant (Filed With SEC on December 15, 2021)

Placement Agent Agreement, dated December 13, 2021, by and between Ampio Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 15, 2021)

Form of Securities Purchase Agreement (Filed With SEC on December 15, 2021)

Employment Agreement, by and between Ampio Pharmaceuticals, Inc. and Michael Martino, dated November 22, 2021 (Filed With SEC on November 29, 2021)

Specimen Common Stock Certificate of the Registrant (Filed With SEC on March 3, 2021)

2019 Stock Incentive Plan and forms of option agreements (Filed With SEC on March 3, 2021)

Amendment No. 3 to Employment Agreement, dated July 13, 2020, between the Company and Daniel Stokely (Filed With SEC on July 14, 2020)

Loan Agreement, dated April 16, 2020, by and between Key Bank National Association and Ampio Pharmaceuticals, Inc (Filed With SEC on April 22, 2020)

Description of Capital Stock of Ampio Pharmaceuticals, Inc (Filed With SEC on February 21, 2020)

Amendment No. 3 to Human Serum Albumin Ingredient Purchase and Sale Agreement among Ampio Pharmaceuticals, Inc., Octapharma USA, Inc. and Nova Biologics, Inc., effective as of... (Filed With SEC on February 21, 2020)

Sales Agreement, dated as of February 20, 2020, by and among ThinkEquity, a division of Fordham Financial Management, Inc., Roth Capital Partners LLC and Ampio Pharmaceuticals, Inc (Filed With SEC on February 20, 2020)

Amendment No. 2 to Employment Agreement, dated December 14, 2019, between the Company and Daniel Stokely (Filed With SEC on December 18, 2019)

Employment Agreement, dated December 14, 2019, between the Company and Michael Macaluso (Filed With SEC on December 18, 2019)

Amendment to Cancellation Agreement, dated November 7, 2019, between Ampio Pharmaceuticals Inc. and Daniel Stokely (Filed With SEC on November 7, 2019)

Form of Warrant Exercise Agreement (Filed With SEC on October 29, 2019)

Employment Agreement, dated September 16, 2019, between the Company and Holli Cherevka (Filed With SEC on September 20, 2019)

Amendment to Employment Agreement, dated August 20, 2019, between the Company and Daniel Stokely (Filed With SEC on August 23, 2019)

Stock Option Cancellation and Grant Agreement for Executive, dated August 20, 2019, between the Company and Daniel Stokely (Filed With SEC on August 23, 2019)

Employment Agreement, dated July 9, 2019, between the Company and Daniel Stokely (Filed With SEC on July 10, 2019)

Placement Agency Agreement, dated June 17, 2019, by and among Ampio Pharmaceuticals, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc (Filed With SEC on June 17, 2019)

Form of Securities Purchase Agreement (Filed With SEC on June 17, 2019)

Form of Lock-Up Agreement (Filed With SEC on June 17, 2019)

Separation Agreement, dated as of June 13, 2019, between Ampio Pharmaceuticals, Inc. and Thomas E. Chilcott, III (Filed With SEC on June 13, 2019)

Equity Distribution Agreement, dated as of April 12, 2019, by and between Canaccord Genuity LLC and Ampio Pharmaceuticals, Inc (Filed With SEC on April 15, 2019)

Form of Warrant Exercise Agreement (Filed With SEC on December 12, 2018)

Form of Warrant Exercise Agreement (Filed With SEC on December 10, 2018)

Underwriting Agreement dated August 9, 2018 by and between Ampio Pharmaceuticals, Inc. and Canaccord Genuity LLC (Filed With SEC on August 13, 2018)

Amendment No. 1 to the Underwriting Agreement dated August 10, 2018 by and between Ampio Pharmaceuticals, Inc. and Canaccord Genuity LLC (Filed With SEC on August 13, 2018)

Form of Warrant (Filed With SEC on August 13, 2018)

Securities Purchase Agreement, dated as of October 15, 2017, by and among Ampio Pharmaceuticals, Inc. and the investors named therein (Filed With SEC on October 16, 2017)

Employment Agreement, dated September 19, 2017 by and between Ampio Pharmaceuticals, Inc. and Holli Cherevka (Filed With SEC on September 22, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on August 29, 2017)

Sponsored Research Agreement Addendum No. 7 (Termination) June 30, 2017 (Filed With SEC on July 7, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 7, 2017)

AMPIO PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on June 6, 2017)

WARRANT TO PURCHASE COMMON STOCK AMPIO PHARMACEUTICALS, INC. (Filed With SEC on June 6, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 6, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2017)

[FORM OF WARRANT] (Filed With SEC on August 29, 2016)

FORM OF COMMON STOCKPURCHASE WARRANT AMPIO PHARMACEUTICALS, INC (Filed With SEC on August 29, 2016)

FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 29, 2016)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 2, 2016)

AGREEMENT (Filed With SEC on March 7, 2016)

AMPIO PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on February 10, 2016)

AMENDMENT NO. 2 TO HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENT (Filed With SEC on October 20, 2015)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)

VOTING AGREEMENT (Filed With SEC on April 22, 2015)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 15, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on June 10, 2014)

***Text Omitted Pursuant to a Request for Confidential Treatment and Filed Separately with the Securities and Exchange Commission Sponsored Research Agreement Addendum No. 4 March... (Filed With SEC on May 7, 2014)

AmpioPharmaceuticals, Inc. 8,500,000 Shares Common Stock ($0.0001 par value) plus an option to purchase from the Company up to 1,275,000additional Shares of Common Stock... (Filed With SEC on February 28, 2014)

HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENT (Filed With SEC on February 14, 2014)

LEASE AGREEMENT by andbetween AMPIO PHARMACEUTICALS, INC. (Tenant) and NCWP - INVERNESSBUSINESS PARK, LLC (Landlord) December 13, 2013 373 INVERNESS PARKWAY TABLE OF CONTENTS (Filed With SEC on December 19, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on October 4, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 26, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 19, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 20, 2012)

Clinical Batch Manufacturing Agreement (the Agreement) ZERTANE ODT [***] Between ETHYPHARM S.A., 194 Bureaux de la Colline, Batîment D, 92213 Saint-Cloud, France (Ethypharm), and... (Filed With SEC on November 2, 2012)

MANUFACTURING AND SUPPLY AGREEMENT by and between ETHYPHARM S.A. and AMPIO PHARMACEUTICALS, INC. * * * (Filed With SEC on November 2, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on September 13, 2012)

UNDERWRITERS (Filed With SEC on July 16, 2012)

4,615,400 Shares of Common Stock AMPIO PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on July 13, 2012)

EXHIBIT A Form of Representatives Warrant Agreement (Filed With SEC on July 13, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on February 9, 2012)

AMPIO PHARMACEUTICALS, INC. Common Stock (par value $0.0001) PLACEMENT AGENT AGREEMENT (Filed With SEC on December 21, 2011)

Form of Subscription Agreement (Filed With SEC on December 21, 2011)

SUBSCRIPTION ESCROW AGREEMENT (Filed With SEC on December 21, 2011)

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN AMPIO PHARMACEUTICALS, INC. AND DAEWOONG PHARMACEUTICALS CO., LTD LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 5, 2011)

AMPIO PHARMACEUTICALS, INC. 5445 DTC Parkway, P4 Greenwood Village, Colorado 80111 (Filed With SEC on June 8, 2011)

EXERCISABLE UNTIL ON OR BEFORE , 2016, 5:00P.M., NEW YORK TIME (Filed With SEC on May 23, 2011)

STANDARD FORM OFFICE LEASE BETWEEN CSHV DENVER TECH CENTER, LLC, a Delaware limited liability company, as Landlord, AND AMPIOPHARMACEUTICALS, INC., a Delaware corporation, as... (Filed With SEC on May 23, 2011)

AMPIO PHARMACEUTICALS, INC. 5445 DTC Parkway, P4 Greenwood Village, Colorado 80111 ###-###-#### PLACEMENT AGENT AGREEMENT (Filed With SEC on April 19, 2011)

ESCROW AGREEMENT (Filed With SEC on April 19, 2011)

EXERCISABLE UNTIL ON OR BEFORE , 2016, 5:00 P.M., NEW YORK TIME (Filed With SEC on April 19, 2011)

PRIVATE PLACEMENT SUBSCRIPTIONAGREEMENT (Accredited and Up To 35 Non-Accredited, Sophisticated Investors) (Filed With SEC on April 19, 2011)

AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 25, 2011)

AMPIO PHARMACEUTICALS, INC. 5445 DTC Parkway, P4 Greenwood Village, Colorado 80111 ATTENTION: CONTAINS SHARE ISSUANCE INSTRUCTIONS IRREVOCABLE INSTRUCTIONSTO TRANSFER AGENT (Filed With SEC on March 16, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on February 15, 2011)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 15, 2011)

AMPIO PHARMACEUTICALS, INC. EXTENTION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $230,000 (Filed With SEC on February 15, 2011)

AMPIO PHARMACEUTICALS, INC. EXTENTION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000 (Filed With SEC on February 15, 2011)

AMPIO PHARMACEUTICALS, INC. NOTE EXTENSION AND SUBORDINATION AGREEMENT (Filed With SEC on February 15, 2011)

DMI LIFE SCIENCES, INC. NOTE EXTENSION AND SUBORDINATION AGREEMENT (Filed With SEC on February 15, 2011)

AGREEMENT AND PLAN OF MERGER BY AND AMONG DMIBIOSCIENCES, INC., AMPIO PHARMACEUTICALS,INC., AMPIO ACQUISITION, INC., AND THE DMI BIOSCIENCES CONTROL SHAREHOLDERS DATED AS OF... (Filed With SEC on January 7, 2011)

DONATION TO CAPITAL AGREEMENT (Filed With SEC on January 7, 2011)

ESCROW AGREEMENT (Filed With SEC on January 7, 2011)

CANCELLATION AGREEMENT (Filed With SEC on January 7, 2011)

DEBT CONVERSION AGREEMENT (Filed With SEC on January 7, 2011)

AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on January 7, 2011)

LOCK-UP AGREEMENT (Filed With SEC on January 7, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2010)

SENIOR UNSECUREDMANDATORILY CONVERTIBLE DEBENTURE (Filed With SEC on November 12, 2010)

WARRANT TO PURCHASECOMMON STOCK AMPIO PHARMACEUTICALS, INC. (Filed With SEC on November 12, 2010)

LOCK-UP AND INVESTMENT REPRESENTATION LETTER (Filed With SEC on November 12, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2010)

AMPIO PHARMACEUTICALS, INC. PROMISSORY NOTE (Filed With SEC on August 16, 2010)

UNSECURED SENIORCONVERTIBLE DEBENTURE (Filed With SEC on August 16, 2010)

WARRANT TO PURCHASE COMMONSTOCK AMPIO PHARMACEUTICALS, INC. (Filed With SEC on August 16, 2010)

DMI LIFE SCIENCES, INC. EXTENSION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000 (Filed With SEC on May 17, 2010)

PLAN OF CONVERSION OF CHAY ENTERPRISES, INC., aColorado corporation, INTO CHAY ENTERPRISES, INC., a Delaware corporation (Filed With SEC on March 30, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2010)

RESTRICTED STOCK AGREEMENT (Filed With SEC on March 17, 2010)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on March 17, 2010)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 17, 2010)

FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 17, 2010)

CHAY ENTERPRISES, INC. d/b/a AMPIO PHARMACEUTICALS,INC. 2010 STOCK AND INCENTIVE PLAN (Filed With SEC on March 17, 2010)

DMI LIFE SCIENCES, INC. AT-WILL EMPLOYMENT,CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT (Filed With SEC on March 17, 2010)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 17, 2010)

INVESTOR RELATIONS CONSULTING AGREEMENT (Filed With SEC on March 17, 2010)

AGREEMENT AND PLAN OF MERGER BY AND AMONG DMI LIFE SCIENCES, INC., CHAYENTERPRISES, INC., AND CHAY ACQUISITIONS,INC. DATED AS OF MARCH 2, 2010 AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 8, 2010)

Category

Industry

Companies

Contracts

Ampio Pharmaceuticals, Inc. Contracts & Agreements